Tauriga Sciences Inc TAUG:OTCQB

Earnings Announcement Next Earnings date is expected on 08/28/2019
Last Price$0.027NASDAQ Last Trade (15-minute delayed) as of 3:26PM ET 8/22/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.003(11.48%)
Bid (Size)$0.03 (40,000)
Ask (Size)$0.03 (11,329)
Day Low / High$0.0253 - 0.03
Volume227.6 K

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionTauriga Sciences, Inc. engages in the development, distribution, and licensing of proprietary products. It also engages in evaluation of potential acquisition opportunities and equity investments. The firm focuses on biotherapeutics and diagnostics, medical devices, and consumer healthcare. Its products include Tauri-GUM which contains cannabidoil. The company was founded on April 8, 2001 and is headquartered in New York, NY. View company web site for more details
Address555 Madison Avenue
New York, New York 10022
Number of Employees2
Recent SEC Filing08/16/2019DEF 14A
Chairman & Chief Executive OfficerSeth M. Shaw
Chief Financial & Accounting OfficerKevin P. Lacey

Company Highlights

Price Open$0.03
Previous Close$0.03
52 Week Range$0.01 - 0.37
Market Capitalization$2.0 M
Shares Outstanding75.9 M
SectorHealth Technology
Next Earnings Announcement08/28/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings0.15
Earnings per Share$0.12
Beta vs. S&P 500N/A
Revenue$57.1 K
Net Profit Margin-1,916.97%
Return on Equity-275.68%